Veeva Vault RIM unites headquarters and local affiliates onto a
shared global system, creating a single source for product registration
information, regulatory correspondence, and archived submissions
PLEASANTON, Calif.--(BUSINESS WIRE)--
Veeva today announced that Bristol-Myers Squibb (NYSE: BMY) has selected Veeva
Vault Registrations and Veeva
Vault SubmissionsArchive, two next generation regulatory solutions
from the Vault RIM suite, to manage registration tracking and submission
archiving globally.
The Vault
RIM suite allows life sciences companies to align regulatory
processes worldwide, improving speed, agility, and compliance. With
Vault RIM companies have real-time access to submission plans, product
registration status, health authority correspondence and commitments,
and local market submissions. The resulting visibility streamlines
global processes and improves data quality, helping companies respond
faster to business changes.
“Life sciences companies struggle to manage product submissions and
registration information around the world,” said John Lawrie, director
of Veeva Vault RIM. “Veeva understands the breadth of this challenge and
has introduced a unified solution that helps harmonize global operations
and provides the visibility organizations need to manage their product
portfolio more effectively.”
Vault RIM is part of Veeva Vault, the first cloud-based regulated
content management platform and suite of applications designed for life
sciences. The Veeva Vault family of applications span clinical, quality,
commercial, medical, and regulatory to ensure one trusted source for
content and data across the enterprise.
Additional Information
For more on Veeva Vault RIM, visit: veeva.com/RIM
Stay
updated on the latest Veeva news on LinkedIn: linkedin.com/company/veeva-systems
Follow
@veevasystems on Twitter: twitter.com/veevasystems
Like
Veeva on Facebook: facebook.com/veevasystems
About Veeva Vault
Veeva Vault is the first cloud-based regulated content management
platform and suite of applications designed for life sciences. It spans
clinical, quality, commercial, medical, regulatory, and every major part
of a global life sciences company to ensure one trusted source for
content and data across the enterprise. Helping companies connect
securely in the life sciences cloud, Vault provides complete control
from start to finish, as well as the easy accessibility, visibility, and
agility needed to speed time to market. All Vault applications offer
real-time reporting and dashboards; an intuitive, consumer-web
interface; and a true multitenant cloud architecture that continuously
delivers rapid innovation. Today, more than 190 customers rely upon
Vault to manage their most important content.
About Veeva Systems
Veeva Systems Inc. is a leader in cloud-based software for the global
life sciences industry. Committed to innovation, product excellence, and
customer success, Veeva has more than 375 customers, ranging from the
world's largest pharmaceutical companies to emerging biotechs. Veeva is
headquartered in the San Francisco Bay Area, with offices in Europe,
Asia, and Latin America. For more information, visit www.veeva.com.
Forward-looking Statements
This release contains forward-looking statements, including the market
demand for and acceptance of Veeva’s products and services, the results
from use of Veeva’s products and services, and general business
conditions, particularly in the life sciences industry. Any
forward-looking statements contained in this press release are based
upon Veeva’s historical performance and its current plans, estimates,
and expectations, and are not a representation that such plans,
estimates, or expectations will be achieved. These forward-looking
statements represent Veeva’s expectations as of the date of this press
announcement. Subsequent events may cause these expectations to change,
and Veeva disclaims any obligation to update the forward-looking
statements in the future. These forward-looking statements are subject
to known and unknown risks and uncertainties that may cause actual
results to differ materially. Additional risks and uncertainties that
could affect Veeva’s financial results are included under the captions,
“Risk Factors” and “Management’s Discussion and Analysis of Financial
Condition and Results of Operations” in the company’s filing on Form
10-Q for the period ended October 31, 2015. This is available on the
company’s website at http://www.veeva.com
under the Investors section and on the SEC’s website at www.sec.gov.
Further information on potential risks that could affect actual results
will be included in other filings Veeva makes with the SEC from time to
time.
View source version on businesswire.com: http://www.businesswire.com/news/home/20160229005216/en/
Source: Veeva Systems Inc.